|
|
|
|
|
by mjewkes
1489 days ago
|
|
>Do you have any data to backup your claim? I would suggest The Great American Drug Deal, by Peter Kolchinsky. Also - https://www.rand.org/pubs/research_briefs/RB9412.html >For example Cuban healthcare/treatment/outcome is excellent based on its own research Cuba does not contribute substantially to global pharmaceutical research. >Roche(Swiss) nor Merck ( German, not related to US Merck) don't benefit much (if at all) from US subsidies. Roche makes 55% of its revenue from US drug sales (https://assets.cwp.roche.com/f/126832/x/db9d31e8a7/fb20e.pdf p22) EMD Serono (formerly Merck KgAA) is similar. These revenues are the topline driver of the drug development industry. |
|